Updates to the HTA Policy and Methods Review Reference Committee (18 January 2024)

18 January 2024 - Communiques for three HTA Review Reference Committee meetings held in December 2023 are now available. ...

Read more →

Public summary documents (first time decisions not to recommend and deferrals) – September 2023 PBAC meeting

12 January 2024 - The public summary documents (first time decisions not to recommend and deferrals) from the September 2023 PBAC ...

Read more →

Updates to the HTA review research and analysis papers collection: draft HTA expert papers published

4 January 2024 - Two draft papers developed to support the deliberations of the HTA Review Reference Committee have been ...

Read more →

Public Summary Documents – September 2023 PBAC meeting

22 December 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2023 PBAC ...

Read more →

PBS Expenditure and Prescriptions Report 2022-23

22 December 2023 - The PBS Expenditure and Prescriptions Report 1 July 2022 to 30 June 2023 is now available. ...

Read more →

Report on the collection of under co-payment data 2022-23

15 December 2023 - The report on the collection of under co-payment data 2022-23 is now available. ...

Read more →

ICER releases draft evidence report on treatment for paroxysmal nocturnal haemoglobinuria

5 December 2023 - Public comment period now open until 9 January 2024; requests to make oral comment during public ...

Read more →

PHARMAC publishes minutes from August 2023 PTAC meeting

3 December 2023 - The meeting was held on 17-18 August 2023. After looking at the agenda, one asks why did ...

Read more →

ICER releases draft evidence report on treatment for schizophrenia

28 November 2023 - Public comment period now open until 22 December 2023; requests to make oral comment during public meeting ...

Read more →

Updates to the HTA Policy and Methods Review Reference Committee (16 November 2023)

16 November 2023 - Two more documents are now available. ...

Read more →

ICER publishes evidence report on treatment for pulmonary arterial hypertension

14 November 2023 - Sotatercept added to background therapy appears to improve clinical outcomes, but there are uncertainties on long ...

Read more →

DUSC utilisation analysis public release documents (June 2023)

14 November 2023 - The utilisation analysis public release documents from the June 2023 DUSC meeting are now available. ...

Read more →

Outcome statement - September 2023 DUSC meeting

13 November 2023 - The Outcome Statement from the September 2023 DUSC meeting is now available. ...

Read more →

Public Summary Documents – July 2023 PBAC meeting (round 2)

10 November 2023 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2023 ...

Read more →

Updates to the HTA Policy and Methods Review Reference Committee (9 November 2023)

9 November 2023 - Two more documents are now available. ...

Read more →